The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
The funding will be spread over four years, with BXLS also eligible for regulatory and commercial milestones, plus royalties on worldwide sales
Duvakitug was well tolerated and safety was consistent with the induction study
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
The Phase 1 study will evaluate the safety, tolerability, and pharmacokinetics (PK) of ENV-6946 in healthy volunteers
Abdomen-pelvis CT is the nation’s highest-volume CT category
A Post Graduate in Science faculty and has a wide experience spanning over 35 years in the field of manufacturing Bulk Drugs and Active Pharmaceutical Intermediaries
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
Subscribe To Our Newsletter & Stay Updated
